Amarin reported -28307000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
DBV Technologies DBVT:US -16771000 2.37M
Abbvie ABBV:US $ 5029M 601M
Aerie Pharmaceuticals AERI:US $ -33643000 85.38M
Alnylam Pharmaceuticals ALNY:US $ -146732000 47.83M
Amarin AMRN:US -28307000 44.04M
AstraZeneca AZN:LN 2.88B 1.57B
Biocryst Pharmaceuticals BCRX:US $ -49957000 2.22M
Epizyme EPZM:US $ -50926000 360K
Esperion Therapeutics ESPR:US $ -42989000 611K
GlaxoSmithKline GSK:LN 2.42B 724M
Halozyme Therapeutics HALO:US $ 75.67M 19.14M
Heron Therapeutics HRTX:US $ -62923000 9.39M
Intercept Pharmaceuticals ICPT:US $ -10272000 10.59M
IONIS PHARMACEUT IONS:US $ -57504000 278.11M
JAZZ PHA JAZZ:US 87.55M 105.43M
Nektar Therapeutics NKTR:US $ -112910000 686K
Novartis NOVN:VX 3.15B 266M
Teva Pharmaceutical Industries TEVA:US 789M 182M